{"pub": "telegraph", "url": "https://telegraph.co.uk/investing/funds/questor-selling-woodford-patient-capital-buying-instead", "downloaded_at": "2019-10-05 14:26:05.602750+00:00", "title": "Questor: why we are selling Woodford Patient Capital \u2013 and what we are buying instead", "language": "en", "text": "Questor investment trust bargain: it\u2019s time to redeploy money to an investment trust that offers a better prospect of future growth\n\nThe time has come: we are pulling the plug on Woodford Patient Capital.\n\nWhy have we run out of, well, patience? It\u2019s quite a list but the first reason is simply that we think the shares have further to fall.\n\nAt first sight, the discount of 34.3pc offers a decent margin of safety in the event of more bad news. But the discount is not all it seems.\n\nAny investment trust discount is based on the net asset value or NAV. If a fund holds quoted stocks, calculating the NAV is straightforward. But if it owns mostly unlisted ones, as Patient Capital does, arriving at a figure...", "description": "Questor investment trust bargain:", "authors": ["Richard Evans", "Matthew Lynn", "Sam Barker", "Katie Morley", "Lauren Davidson", "Marianna Hunt", "Taha Lokhandwala", "Stephanie Baxter"], "top_image": "https://www.telegraph.co.uk/content/dam/investing/2019/10/02/TELEMMGLPICT000200515649-xlarge_trans_NvBQzQNjv4BqH4D-jx1ezwmwmru7Y7fiE2wqu6Iu0FuYzRTYfHcrDC0.jpeg?imwidth=1200", "published_at": "2019-10-02"}